Desferrithiocin polyether analogues
AssigneesUniversity of Florida Research Foundation, Inc., University of Florida, The United States of America as represented by the National Institutes of Health (NIH), The United States of America as represented by the Department of Health and Human Services
InventorRaymond J. Bergeron, Jr.
Life of this patent
Estimating the term…
Abstract
Compounds represented by structural formulas described herein, such as Structural Formula (I): or a pharmaceutically acceptable salt thereof are useful in treating conditions such as metal overload, oxidative stress, and neoplastic and preneoplastic conditions.
Claims18
A compound represented by Structural Formula (I):
- wherein:
- R1 is —H or an acyl group;
- R2 is —[(CH2)n—O]x—[(CH2)n—O]y—R′;
- R3, R4 and R5 are each —H;
- R6 and R7 are each —H;
- R8 is —H or an alkyl group;
- R9 is —OR12 or —N(OH)R13;
- R10 is —H or an alkyl group;
- R11 is —H, an alkyl group or an acyl group;
- R12 is —H or an alkyl group;
- R13 is an alkyl group;
- R14 is an alkyl group;
- R′ is an alkyl group;
- m is an integer from 1 to 8;
- each n is independently an integer from 1 to 8;
- x is an integer from 1 to 8;
- y is an integer from 0 to 8;
- Z is —C(O)R14, or
- or a salt thereof.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by Structural Formula (I):
- wherein:
- R1 is —H or an acyl group;
- R2 is —[(CH2)n—O]x—[(CH2)n—O]y—R′;
- R3, R4 and R5 are each —H;
- R6 and R7 are each —H;
- R8 is —H or an alkyl group;
- R9 is —OR12 or —N(OH)R13;
- R10 is —H or an alkyl group;
- R12 is —H or an alkyl group;
- R13 is an alkyl group;
- R14 is an alkyl group;
- R′ is an alkyl group;
- m is an integer from 1 to 8;
- each n is independently an integer from 1 to 8;
- x is an integer from 1 to 8;
- y is an integer from 0 to 8;
- Z is —C(O)R14, or
- or a pharmaceutically acceptable salt thereof.
A method of treating trivalent metal overload in a subject, comprising administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I):
- wherein:
- R1 is —H or an acyl group;
- R2 is —[(CH2)n—O]x—[(CH2)n—O]y—R′;
- R3, R4 and R5 are each —H;
- R6 and R7 are each —H;
- R8 is —H or an alkyl group;
- R9 is —OR12 or —N(OH)R13;
- R10 is —H or an alkyl group;
- R12 is —H or an alkyl group;
- R13 is an alkyl group;
- R14 is an alkyl group;
- R′ is an alkyl group;
- m is an integer from 1 to 8;
- each n is independently an integer from 1 to 8;
- x is an integer from 1 to 8;
- y is an integer from 0 to 8;
- Z is —C(O)R14, or
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.